- US economic uncertainty to spark boom in UK real estate investing
- East Africa’s Real Estate Market Primed for Those Who Know It Best
- AVCA’S Fifth VC Summit Spotlights: Resilience, Scale and Bankability
- Commodities Weekly - Framing tariff-induced stagflation risks
- African Private Capital Fundraising Doubles to $4bn in 2024
French Drugs Maker Targets Africa With Nigerian Acquisition
LAGOS (Capital Markets in Africa) – Biogaran SAS, a closely held French pharmaceuticals manufacturer, plans to tap into Nigeria’s $1.3 billion drugs market as a launchpad for its expansion into Africa, company President Pascal Briere said. The unit of France’s second-largest drug maker, Les Laboratoires Servier, last month acquired Nigeria’s Swipha Limited. after an initial $500,000 investment. Biogaran expects Nigeria’s pharmaceuticals industry to grow by more than 12 percent annually. “We found that Nigeria is well adapted for what we…
Read More